ADCT vs HMC
ADC Therapeutics SA (ADCT) versus HMC (HMC) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
HMC (HMC) common stock.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
HMC does not have a complete income-statement cache yet.
ADCT currently screens at market cap $141.2M. HMC currently screens at market cap $0.
Not investment advice. Open the ADCT and HMC stock pages for the full models.
Not investment advice.